<<

584 Analysis of data collected by the Swedish Medical Birth Regis- means of removing or its metabolite mito†; Alviumthe†; Bisincof; Bramin; Bronar; Broquixol; Celestamine NS; try between 1994 and 2001 revealed 15 cases of hypospadias from the body.1 Claricort†; Clariflu; Clarifriol; Clarinase†; Clarityne D; Coricidin Expec; among a cohort of 2780 newborns exposed to loratadine during Dimegan D; Doralan-Ax; Efectine D; Farmalor; Fluxibit; Gralddep; Laritol D; 1 1. Matzke GR, et al. Pharmacokinetics of loratadine in patients Laritol Ex; Laritol G; Lertamine D; Linfarden; Lovarin P†; Lyrsedin; Neoalexil the first trimester of pregnancy. The authors noted that the indi- with renal insufficiency. J Clin Pharmacol 1990; 30: 364–71. P†; Quimtadine DSQ; Quimtafriol; Sensibit D; Sensibit XP; Sibilex; Tadinar- vidual risk for having an infant with hypospadias after loratadine C; Tamex; Tavexyl; TheraFlu 24; TheraFlu N 12; TheraFlu TD; NZ: Clari- use is small (less than 1%) and the attributive risk of extra cases nase†; Demazin Non-Drowsy†; Philipp.: Claricort; Clarinase; Rhinase; in the population is low. The US CDC has also analysed data Uses and Administration Pol.: Clarinase; Port.: Claridon; S.Afr.: Clarityne D; Demazin NS; Polara- 2 tyne D†; Singapore: Clarinase; Spain: Narine; Thai.: Clarinase; Turk.: from the National Birth Defects Prevention study; they found no Loratadine, a piperidine derivative related to , Clarinase; USA: Alavert Allergy & Sinus D; Claritin-D; Venez.: Ambroclar; increase in the risk of second- or third-degree hypospadias in the is a long-acting, non-sedating with no Celestamincort; Claricort; Claridex; Claridexultra; Clariflu; Clarigrip; Clari- infants of women who used loratadine in early pregnancy. In ad- nase†; Fedyclar; Lokarin; Loracert; Rinase†. 3 significant antimuscarinic activity. It is used for the dition, an earlier prospective multicentre study in 161 women symptomatic relief of allergic conditions including taking a median dose of loratadine 10 mg daily in the first trimes- rhinitis (p.565) and chronic urticaria (p.565). ter of pregnancy suggested that its use was not associated with a Mebhydrolin (BAN, rINN) significant risk of major congenital malformations. Loratadine is given in an oral dose of 10 mg once daily. 1. Källén B, Olausson PO. Monitoring of maternal drug use and Mebhidrolina; Mebhydroline; Mebhydrolinum. 5-Benzyl-1,2,3,4- infant congenital malformations: does loratadine cause hypospa- Children aged 2 to 5 years may be given 5 mg once tetrahydro-2-methyl-γ-carboline. dias? Int J Risk Safety Med 2001; 14: 115–19. daily and those aged 6 to 12 years may be given 10 mg Мебгидролин 2. CDC. Evaluation of an association between loratadine and hyp- once daily for seasonal allergic rhinitis and chronic id- ospadias — United States, 1997-2001. MMWR 2004; 53: C19H20N2 = 276.4. 219–21. Also available at: http://www.cdc.gov/mmwr/PDF/wk/ iopathic urticaria. CAS — 524-81-2. mm5310.pdf (accessed 11/05/04) ATC — R06AX15. 3. Moretti ME, et al. Fetal safety of loratadine use in the first tri- It is also used with a decongestant such as pseudoephe- ATC Vet — QR06AX15. mester of pregnancy: a multicenter study. J Allergy Clin Immu- drine sulfate. nol 2003; 111: 479–83. Sedation. For discussion of the sedative effects of antihista- For dosage in hepatic or renal impairment, see below. CH3 N mines see p.562. ◊ References. 1. Haria M, et al. Loratadine: a reappraisal of its pharmacological Interactions properties and therapeutic use in allergic disorders. Drugs 1994; As for the non-sedating antihistamines in general, 48: 617–37. N p.563. Administration in hepatic or renal impairment. US Loratadine is metabolised by cytochrome P450 isoen- product information recommends that patients with hepatic fail- zymes CYP3A4 and CYP2D6. Therefore use with oth- ure or renal impairment (glomerular filtration rate less than er drugs that inhibit or are metabolised by these hepatic 30 mL/minute) should be given an initial oral dose of loratadine 10 mg on alternate days. enzymes may result in changes in plasma concentra- tions of either drug and, possibly, adverse effects. Preparations Mebhydrolin Napadisilate (BANM, rINNM) Drugs known to inhibit one or other of these enzymes USP 31: Loratadine Oral Solution; Loratadine Tablets. Diazolinum; Mebhydrolin Napadisylate; Mebhydrolin Naphtha- include , erythromycin, ketoconazole, quini- Proprietary Preparations (details are given in Part 3) lenedisulphonate; Mebhydroline, Napadisilate de; Mebhydrolini dine, fluconazole, and fluoxetine. Arg.: Aerotina; Alergipan; Alermuc; Alerpriv; Algistop; Aseptobron Napadisilas; Napadisilato de mebhidrolina. Mebhydrolin naph- Antibacterials. Data held on file by the manufacturer show Descongestivo; Bedix; Benadryl 24; Biloina; Bioaler†; Clarityne; Devedryl; thalene-1,5-disulphonate. Hisplex; Lertamine†; Lisaler; Loisan; Loratex†; Loratine; Loremex Antialer- that erythromycin can inhibit the metabolism of loratadine. How- gico; Nastizol Antialergico†; Negalerg L†; Niltro; Novo Vagran†; Nularef; Мебгидролина Нападизилат ever, even when given in large doses loratadine does not appear Omega 100 L; Pulmosan Aller; Sinaler; Tabcin Alergia; Vagran; Vixidone L; (C19H20N2)2,C10H8O6S2 = 841.0. to cause the cardiac conduction disorders associated with the Austral.: Alledine; AllerEze; Claratyne; Lorano; Lorastyne†; Austria: Aller- CAS — 6153-33-9. non-sedating antihistamines (see p.567) and terfena- non; Clarityn; Lictyn; Lorano; Loratyn; Belg.: Claritine; Rupton; Sanelor; ATC — R06AX15. 1 Braz.: Alergaliv; Atinac†; Clarilerg†; Claritin; Clistin†; Histadin; Histamix†; dine (see p.590). Similarly, clarithromycin seemed to inhibit the Loradine; Loralerg; Loranil; Lorasc†; Loratamed; Loremix; Loritil; Neo Lo- ATC Vet — QR06AX15. metabolism of loratadine and its active metabolite deslorata- ratadin; Canad.: Claritin; Chile: Alergan; Alledryl; Clarityne; Frenaler; 2 Profile dine. Histaplus†; Hysticlar; Larmax†; Lontadex; Cz.: Claritine; Erolin; Flonidan; Mebhydrolin, an derivative, is a sedating anti- Loranol; Roletra; Denm.: Clarityn; Geklimon†; Loritin; Mildin; Oratyn; Ver- 1. Affrime MB, et al. Three month evaluation of electrocardio- (p.561) with antimuscarinic and sedative properties. It graphic effects of loratadine in humans. J Allergy Clin Immunol sal†; Fin.: Clarityn; Geklimon†; Tuulix; Fr.: Clarityne; Ger.: Lisino; Livotab†; 1993; 91: 259. Lobeta; Lora; Lora-Lich; Lora-Puren; Loraclar†; Loraderm; Loragalen; Lora- has been given orally as the base or as the napadisilate salt for the lerg†; Lorano; Loratadura; Loratagamma; Loravis; Vividrin Loratadin†; Gr.: 2. Carr RA, et al. Steady-state pharmacokinetics and electrocardi- symptomatic relief of allergic conditions including urticaria and Allerdrug; Allergofact; Biliranin†; Bollinol; Clarityne; Difmedol; Helporigin; rhinitis, and in pruritic skin disorders. Granulocytopenia and ographic pharmacodynamics of clarithromycin and loratadine Horestyl; Igir; Latoren; Lora; Loratab; Novacloxab; Ralinet; Ristotadin; Tir- after individual or concomitant administration. Antimicrob lor; Utel; Zelmar; Hong Kong: Allertyn; Ambrace; Carin; Clarityne; CP- agranulocytosis have been reported. Agents Chemother 1998; 42: 1176–80. Loradine; Erolin; Ezede; Loradin; Loraton; Lotadine; Lotin; Marlora; Rinityn; Preparations Antifungals. Ketoconazole also appears to be able to inhibit the Rotifar; Voratadine; Hung.: Claritine; Erolin; Flonidan; Lorano; Roletra; In- dia: Awayke†; Loratin; Lorfast; Loridin; Lorin; Indon.: Alernitis; Allohex; Proprietary Preparations (details are given in Part 3) metabolism of loratadine and at therapeutic doses, is about 3 Alloris; Anhissen; Anlos; Clarihis; Claritin; Clatatin; Cronitin; Folerin; Hislo- Indon.: Biolergy; Gabiten; Histapan; Incitin; Interhistin; Tralgi; Zoline; Israel: times more inhibitory than erythromycin.1 However, the concen- rex; Histaritin; Imunex; Inclarin; Klinset; Lergia; Lesidas; Lolergi; Loran; Lorap- Cidalin; Rus.: Diazolin (Диазолин); S.Afr.: Fabahistin; Thai.: Dalhis; Day- trations of ketoconazole required are reported to be much higher harm; Lorihis; Nosedin; Prohistin; Pylor; Rahistin; Rihest; Safetin; Sohotin; hist; Manocidal; Manoeidai; Posidol. than those required to inhibit the metabolism of astemizole or Tinnic; Winatin; Irl.: Clarityn†; Histaclar; Israel: Lorastine; Loratrim; Ital.: Alorin†; Clarityn; Fristamin; Jpn: Claritin; Malaysia: Carin; Clarityne; . Clearance of the active metabolite desloratadine is Ezede†; Loradine; Lorastyne†; Loratyn†; Ridamin; Roletra; Tirlor; Mex.: also reduced. Alerfin; Aludix; Antilergal; Biolorat; Clarityne; Curyken; Dimegan; Dissen; 1. Brannan MD, et al. Effects of various cytochrome P450 inhibi- Ditana; Doralan; Dotagil; Dymaten; Efectine; Fartadin; Grimeral; Histina; Meclozine Hydrochloride tors on the metabolism of loratadine. Clin Pharmacol Ther 1995; Histox; Inigrin; Laritol; Lertamine; Lictyn; Liferamin; Lotan; Lovarin; Neoalex- 57: 193. il; Nidatar; Quimtadine; Rodakin; Rokadin†; Sensibit; Serralsina; Sitinir; Vin- (BANM, pINNM) cidal; Neth.: Allerfre; Claritine; Kruidvat Hooikoortstabletten; Lorastad; Ot- Gastrointestinal drugs. Cimetidine appears to have an inhib- rivin neusallergie loratadine; Sanelor; Norw.: Clarityn; Versal†; NZ: Hidrocloruro de meclozina; Hydrochloride; Meclizin- itory effect on the metabolism of loratadine and also attenuates Claratyne; Lora-Tabs; Philipp.: Allerta; Claritin; Lergicyl; Loradex; Lorahist; ium Chloride; Méclozine, chlorhydrate de; Meclozini Dihydro- the clearance of its active metabolite desloratadine although no Lorano; Loratyne; Lordam; Lordane; Onemin; Rinityn; Zylohist; Pol.: Aler- chloridum; Meclozini hydrochloridum; Meklotsiinihydrokloridi; 1 fan; Aleric; Claritine; Flonidan; Lorahexal; Loram; Loratan; Loratine; Nal- clinically significant consequences have been seen. ergine; Rotadin; Port.: Alertrin; Claritine; Evertine; Histadin; Profenox; Meklozin Hidroklorür; Meklozin-dihydrochlorid; Meklozin-hid- 1. Brannan MD, et al. Effects of various cytochrome P450 inhibi- Zolargene; Rus.: Alerpriv (Алерприв); Clargotil (Кларготил); Clarisens roklorid; Meklozinhydroklorid; Meklozino hidrochloridas; Mek- tors on the metabolism of loratadine. Clin Pharmacol Ther 1995; (Кларисенс); Claritine (Кларитин); Clarotadine (Кларотадин); Erolin lozyny chlorowodorek; Parachloramine Hydrochloride. 1-(4- 57: 193. (Эролин); Klallergine (Клаллергин); Klarfast (Кларфаст); Klaridol (Кларидол); Lomilan (Ломилан); Lorahexal (Лорагексал); Lorid (Лорид); Chlorobenzhydryl)-4-(3-methylbenzyl) dihydrochlo- Loridin (Лоридин); S.Afr.: Clarinese; Clarityne; Demazin Anti-Allergy†; ride. Pharmacokinetics Laura; Lorahist; Lorano; Loratyne†; Polaratyne†; Pollentyme; Rhinigine; Sin- Loratadine is rapidly absorbed from the gastrointesti- gapore: Allertyn; Ardin; Carin; Clarityne; Ezede; Histalor; Lorfast; Loridin; Меклозина Гидрохлорид Lotadine; Ridamin; Rinityn; Roletra; Tirlor; Spain: Civeran; Clarityne; Fadi- C H ClN ,2HCl = 463.9. nal tract after oral doses, peak plasma concentrations 25 27 2 na†; Optimin†; Velodan; Swed.: Clarityn; Versal; Switz.: Claritine; Thai.: CAS — 569-65-3 (meclozine); 1104-22-9 (anhydrous being attained in about 1 hour. Bioavailability is in- Aller-Tab; Allerdine; Allersil; Caradine; Carinose†; Clalodine; Clarid; Clarit- yne; Halodin; Hisracon; Klaryne; Lindine; Loracine; Loradine; Loranox; Lor- meclozine hydrochloride); 31884-77-2 (meclozine hydro- creased and time to peak plasma concentrations is de- din; Lorin; Lorita; Lorityne†; Lorsedin; Lortadine; Ridamin; Rityne; Roletra; chloride monohydrate). layed when taken with food. Loratadine undergoes ex- Tiradine; Tirlor; Turk.: Alarin; Claritine; Histadin; Loradif; Lorantis; Loritine; Ritin; UAE: Loratin; UK: Clarityn; USA: Alavert; Claritin; Clear-Atadine; ATC — R06AE05. tensive metabolism. The major metabolite, Non-Drowsy Allergy; Tavist ND; Venez.: Alerdina; Alertidine†; Biolorat; ATC Vet — QR06AE05. desloratadine (p.576), has potent antihistaminic activi- Clarityne; Loradin†; Lorat; Loraval; Lorex; Loriden; Lotal; Polaramine Refor- ty. Reported mean elimination half-lives for loratadine mulado; Proactin†; Tirlor. Multi-ingredient: Arg.: Alerpriv D; Bedix-D; Benadryl 24 D; Celes- and desloratadine are 8.4 and 28 hours, respectively. tamine-L; Ciprocort D; Ciprocort L; Clarifriol; Clarityne Cort; Clarityne D; Loratadine is about 98% bound to plasma proteins; Cortistamin L; Decidex Plus; Dexaprof D; Histamino Corteroid L; Ideogrip; Lertamine D†; Lisaler Beta; Loisan-D; Loremex Descongestivo; Nastizol-L; desloratadine is less extensively bound. Loratadine and Negalerg†; Novo Vagran D†; Novo-Nastizol†; Nularef Cort; Nularef-D; Pa- CH3 its metabolites have been detected in breast milk, but racetamol Grip NF; Pulmonix Grip; Pulmonix Plus; Sinaler B; Toraxan; Va- gran D; Vixidone LB; Austral.: Clarinase; Sinease†; Austria: Clarinase; do not appear to cross the blood-brain barrier to a sig- Belg.: Clarinase; Braz.: Claritin-D; Cloratadd D; Histadin D; Loralerg-D; N nificant extent. Most of a dose is excreted equally in the Loranil D; Loremix D; Neofedrin; Canad.: Chlor-Tripolon ND; Claritin Al- lergy & Sinus; Claritin Extra†; Liberato; Chile: Alledryl D; Clarinase; Frenal- N urine and faeces, mainly in the form of metabolites. er-D; Larmax D; Lertamine; Lertamine Extra; Lontadex D†; Rinomex; Cz.: Cl Clarinase; Denm.: Clarinase; Fin.: Clarinase; Fr.: Clarinase; Gr.: Clarityne Renal impairment. The disposition of loratadine does not ap- D; Hong Kong: Clariflu; Clarinase; Rhinos; Hung.: Clarinase; India: Loratin pear to be significantly altered in patients with severe renal im- D; Lorfast-D; Loridin-D; Indon.: Aldisa; Clarinase; Glanos; Rhinos; Israel: (meclozine) pairment and haemodialysis does not appear to be an effective Clarinase; Malaysia: Carinox; Clarinase; Mex.: Alerfin Ex; Alvium†; Alviu-